BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for BioMarin (United Kingdom), United Kingdom, covering academic research published from 2010 to 2023. Read More.
Open Access Percentage
79%
Total
Publications
80
Total Open
Publications
63
Total
Citations
1.8K
Open Access
Percentage
79%
Total
Publications
80
Total Open
Publications
63
Total
Citations
1.8K
Breakdown
Publisher Open
23%
Both
55%
Other Platform Open
1%
Closed
21%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 52%
32
Hybrid 45%
28
No Guarantees 3%
2
Other Platform Open
Domain 84%
38
Institution 38%
17
Other Internet 7%
3
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 37 |
University College London - UCL Discovery | Institution | 9 |
Europe PMC | Domain | 8 |
University of California - eScholarship University of California | Institution | 4 |
AECID Library - Americanae | Institution | 3 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 2 |
University of Birmingham - University of Birmingham Research Portal | Institution | 2 |
unimelb.edu.au OAI-PMH Repository | Institution | 2 |
Erasmus University Rotterdam - EUR Research Repository | Institution | 2 |
Elsevier - Scopus | Other Internet | 2 |